ASCO 2023: Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Browsing: advanced lung cancer
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise…
Early palliative care for advanced lung cancer increases survival
Early palliative care is associated with better survival in patients with advanced lung cancer, according…
Lung cancer patients with anxiety, depression die sooner
Patients who experience anxiety and depression after being diagnosed with advanced lung cancer are more…
Sleep apnea may make lung cancer more deadly
A team of researchers from the University of Chicago and the University of Barcelona has…
Lung cancer patients whose tumour has spread to the brain could be spared WBRT
Patients with non-small cell lung cancer which has spread to the brain could be spared…
ASCO 2016: Mobile-friendly web application extends lung cancer survival
A Web-mediated follow-up application (MoovcareTM) improves advanced lung cancer survival, according to a French multicentre randomised phase…
A potential therapy for the most aggressive type of lung cancer in preclinical models
Lung cancer is one of the most prevalent types of cancer, with more than 20,000…